One MDS patient who had lung cancer treated with nivolumab+azacitidine. The immunostimulatory effect

Yukitsugu Nakamura

Presentation information

Oral Session

Oral Session 3-11D MDS：AZA Treatment

Sun. Oct 13, 2019 3:40 PM - 4:40 PM No.11 (Tokyo International Forum, 5F G502)

Chair: Tomoko Hata (Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University)

[OS3-11D-5] One MDS patient who had lung cancer treated with nivolumab+azacitidine. The immunostimulatory effect

Yukitsugu Nakamura^1,2, Yoshitomo Kushima¹, Dasisuke Asahara¹ (1.Int. Med., Japanese Red Cross Ashikaga Hospital., Ashikaga, Japan, 2.Ishimoto Hospital, Ishii, Kasama, Ibaraki, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.